🇺🇸 FDA
Pipeline program

Pegtibatinase, 0.9 % sodium chloride saline solution (NaCL)

TVTX-TVT058-301

Phase 3 small_molecule active

Quick answer

Pegtibatinase, 0.9 % sodium chloride saline solution (NaCL) for Classical Homocystinuria is a Phase 3 program (small_molecule) at Travere Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Travere Therapeutics
Indication
Classical Homocystinuria
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials